483
Carnegie Pharmaceutical LlcCarnegie Pharmaceutical Llc – FDA 483, Jun 29, 2021
Record Details
An FDA inspection of Carnegie Pharmaceuticals, LLC in Delran, NJ, revealed significant deficiencies in quality control and manufacturing practices. Observations included failures to follow written procedures for component identification, inadequate establishment of test method accuracy and sensitivity for impurities, and insufficient laboratory controls for pH meter calibration and temperature monitoring. These issues indicate a lack of assurance in drug product quality and purity.
View Company Profile
ID · 92cf3260-3e24-4353-b968-034e518ae786
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.